跳至主要内容
临床试验/CTRI/2022/06/043615
CTRI/2022/06/043615尚未招募不适用

Efficacy of combination of therapeutic patient education with standard of care versus standard of care alone for the management of chronic migraine: A randomized controlled trial

Not applicable1 个研究点 分布在 1 个国家目标入组 126 人开始时间: 2022年1月7日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
126
试验地点
1
主要终点
Change in Migraine Specific Quality of Life Score from baseline per 4 weeks for weeks 9-12 weeks

研究概览

简要总结

The study is a randomised control trial to objectively measure the efficacy of therapeutic patient education with standard of care compared with standard of care alone for the management of chronic migraine.

Chronic migraine is a prevalent, debilitating condition that affects patients lifelong and hampers their everyday life and productivity. While drug treatment is available, it comes with its own caveat of Medicine Overuse Headache (MOH), and other side effects. There is burning need for behavioral interventions such as education to make lifestyle modifications that lead towards better patient outcome. This is key to health promotion.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • •Any patient fulfilling diagnostic criteria for chronic migraine with or without aura as laid by ICHD-3 (International Classification of Headache Disorders).

排除标准

  • •All patients with a clinical phenotype of chronic migraine but on further investigation, found to have a secondary cause for their headache.

结局指标

主要结局

Change in Migraine Specific Quality of Life Score from baseline per 4 weeks for weeks 9-12 weeks

时间窗: 12 weeks

次要结局

  • Change in mean Headache Impact Test-6 from baseline per 4 weeks for weeks 9-12 weeks(12 weeks)
  • Change in mean Migraine Disability Assessment from baseline per 4 weeks for weeks 9-12 weeks(12 weeks)

研究者

发起方
Not applicable
申办方类型
Other [nil]

研究点 (1)

Loading locations...

相似试验